About Oova
Oova is a company based in New York (United States) founded in 2017 by Aparna Divaraniya. Oova has raised $12.5 million across 4 funding rounds from investors including Virgin, Jefferson Health and US Fertility. Oova offers products and services including Fertility Hormone Kit, Perimenopause Hormone Kit, and Oova App. Oova operates in a competitive market with competitors including Inito, kegg, MyHealthChecked, Ava and Glow, among others.
- Headquarter New York, United States
- Founders Aparna Divaraniya
-
Sectors
ConsumerHealthcare Technology
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Oova, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$12.5 M (USD)
in 4 rounds
-
Latest Funding Round
$10.3 M (USD), Series A
Jun 12, 2023
-
Investors
Virgin
& 10 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Oova
Oova offers a comprehensive portfolio of products and services, including Fertility Hormone Kit, Perimenopause Hormone Kit, and Oova App.
Tests hormones to identify and confirm ovulation for conception support.
Monitors hormones to track perimenopause symptoms and patterns.
App provides insights on hormone levels for cycle management.
People of Oova
Unlock access to complete
Unlock access to complete
Funding Insights of Oova
Oova has successfully raised a total of $12.5M across 4 strategic funding rounds. The most recent funding activity was a Series A round of $10.3 million completed in June 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Oova
Oova has secured backing from 11 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include Virgin, Jefferson Health and US Fertility.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
A boutique venture firm is focused on purpose-led companies.
|
Locked | Locked | Locked | |
|
Venture capital services for biotech, IT, and innovative sectors in Connecticut.
|
Locked | Locked | Locked | |
|
Venture capital fund investing in early-stage tech startups
|
Locked | Locked | Locked |
Investor details for Oova
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Oova
Investment portfolio details for Oova
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Oova
Detailed financials for Oova
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Oova Comparisons
Peer comparison for Oova
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Oova
Oova operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Inito, kegg, MyHealthChecked, Ava and Glow, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Test devices are provided for at-home fertility hormone tracking.
|
|
| Locked | Locked | Locked |
Fertility tracking and pelvic health solutions are provided by kegg.
|
|
| Locked | Locked | Locked |
Online platform for ordering Covid-19 diagnostic test kits is operated.
|
|
| Locked | Locked | Locked |
AI-based transcription and captioning services are provided for multiple applications.
|
|
| Locked | Locked | Locked |
Fertility is tracked via menstrual cycle data and symptoms.
|
|
| Locked | Locked | Locked |
Provider of software solutions and Q- pad for women's health monitoring & tracking
|
Detailed competitors of Oova
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Oova
Complete news archive for Oova
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Oova
Oova was founded in 2017 and raised its 1st funding round 2 years after it was founded.
Oova is headquartered in New York, United States. It is registered at New York, New York, United States.
Aparna Divaraniya is the current CEO of Oova. They have also founded this company.
Oova is a funded company, having raised a total of $12.5M across 4 funding rounds to date.
Oova was established in 2017 in New York, United States, by Aparna Divaraniya as founder and CEO. A digital platform is provided for fertility tracking, enabling users to monitor hormone levels and reproductive metrics through at-home testing kits and app-based analysis. Operations focus on the health technology sector, with services targeted at individuals and healthcare providers seeking data-driven fertility insights. Geographic emphasis is placed on the U.S. market.
Oova's top competitors include kegg, Ava and MyHealthChecked.
Oova offers Fertility Hormone Kit, Perimenopause Hormone Kit, and Oova App.
Oova has 11 investors. Key investors include Virgin, Jefferson Health, US Fertility, Spero, and Connecticut Innovations.